Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Baxter
Johnson and Johnson
QuintilesIMS
UBS
Covington
Julphar
Merck
AstraZeneca
Daiichi Sankyo

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017067

« Back to Dashboard

NDA 017067 describes CHORIONIC GONADOTROPIN, which is a drug marketed by Bel Mar, Ferring, and Fresenius Kabi Usa, and is included in three NDAs. It is available from two suppliers. Additional details are available on the CHORIONIC GONADOTROPIN profile page.

The generic ingredient in CHORIONIC GONADOTROPIN is gonadotropin, chorionic. Four suppliers are listed for this compound. Additional details are available on the gonadotropin, chorionic profile page.
Summary for 017067
Tradename:CHORIONIC GONADOTROPIN
Applicant:Fresenius Kabi Usa
Ingredient:gonadotropin, chorionic
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 017067
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017067 NDA Fresenius Kabi USA, LLC 63323-025 63323-025-10 1 KIT in 1 PACKAGE (63323-025-10) * 10 mL in 1 VIAL, MULTI-DOSE * 10 mL in 1 VIAL, MULTI-DOSE
CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017067 NDA Fresenius Kabi USA, LLC 63323-030 63323-030-11 1 KIT in 1 CARTON (63323-030-11) * 10 mL in 1 VIAL, MULTI-DOSE * 10 mL in 1 VIAL, MULTI-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength5,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength20,000 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Merck
UBS
Chinese Patent Office
Baxter
Cantor Fitzgerald
Teva
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot